Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods

A Meijer1, P J Roholl, S K Gielis-Proper

  • 1Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands. Adam.Meijer@rivm.nl

Abstract

Insights

This study developed methods to detect Chlamydia pneumoniae in situ and assess bacterial viability. Inclusion-like staining indicates viable bacteria, while granular staining suggests non-viable Chlamydia pneumoniae.

Area of Science:

  • Microbiology
  • Pathology
  • Immunology

Background:

  • Discrepancies exist in detecting Chlamydia pneumoniae in atherosclerotic lesions using immunocytochemistry versus PCR.
  • Accurate detection and viability assessment of C. pneumoniae are crucial for understanding its role in disease.

Purpose of the Study:

  • To evaluate methods for in situ detection of Chlamydia pneumoniae.
  • To assess the viability of C. pneumoniae within infected cells and tissues.

Main Methods:

  • Immunocytochemistry was used to detect C. pneumoniae antigens (membrane protein, HSP60, LPS).
  • In situ hybridization detected genomic DNA and 16S rRNA.
  • Experiments were conducted on infected HEp2 cells and mouse lungs.

Main Results:

  • Inclusions reactive for antigens, DNA, and 16S rRNA indicated viable C. pneumoniae in HEp2 cells and mouse lungs up to 7 days post-infection.
  • Granular antigen staining alone, without DNA/16S rRNA detection, was observed in macrophages and infiltrate cells at 21 days, suggesting non-viable bacteria.
  • Sporadic DNA/16S rRNA detection with inclusion-like staining occurred at 21 days.

Conclusions:

  • Inclusion-like staining for antigens, DNA, and 16S rRNA is indicative of viable Chlamydia pneumoniae.
  • Granular antigen staining without nucleic acid detection suggests non-viable bacteria.
  • The developed methods are suitable for in situ detection and viability assessment of C. pneumoniae.